Bank Of New York Mellon Corp Mersana Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $2.08 Million - $2.89 Million	368,029 New	368,029 $2.16 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $78,172 - $135,072	16,884 Added 4.91%	360,596 $2.44 Million
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $172,152 - $303,085	60,617 Added 21.41%	343,712 $1.59 Million
Q1 2022 May 11, 2022	BUY	$3.74 - $6.63 $11,837 - $20,983	3,165 Added 1.13%	283,095 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$5.48 - $9.86 $49,983 - $89,933	9,121 Added 3.37%	279,930 $1.74 Million
Q3 2021 Nov 12, 2021	BUY	$8.56 - $14.47 $186,676 - $315,561	21,808 Added 8.76%	270,809 $2.55 Million
Q2 2021 Aug 11, 2021	SELL	$13.28 - $18.07 $166,132 - $226,055	-12,510 Reduced 4.78%	249,001 $3.38 Million
Q1 2021 May 13, 2021	SELL	$15.31 - $26.52 $229,144 - $396,924	-14,967 Reduced 5.41%	261,511 $4.23 Million
Q4 2020 Feb 09, 2021	SELL	$16.84 - $27.59 $31,894 - $52,255	-1,894 Reduced 0.68%	276,478 $7.36 Million
Q3 2020 Nov 12, 2020	BUY	$16.2 - $25.7 $113,902 - $180,696	7,031 Added 2.59%	278,372 $5.18 Million
Q2 2020 Aug 12, 2020	BUY	$5.24 - $23.4 $399,927 - $1.79 Million	76,322 Added 39.14%	271,341 $6.35 Million
Q1 2020 May 06, 2020	BUY	$4.41 - $9.28 $3,422 - $7,201	776 Added 0.4%	195,019 $1.14 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $135,057 - $626,852	93,143 Added 92.13%	194,243 $1.11 Million
Q3 2019 Nov 07, 2019	SELL	$1.54 - $4.2 $9,395 - $25,624	-6,101 Reduced 5.69%	101,100 $159,000
Q2 2019 Aug 12, 2019	BUY	$3.84 - $6.4 $262,874 - $438,124	68,457 Added 176.69%	107,201 $434,000
Q1 2019 May 14, 2019	SELL	$3.51 - $7.3 $1,611 - $3,350	-459 Reduced 1.17%	38,744 $204,000
Q4 2018 Feb 11, 2019	BUY	$3.45 - $9.72 $21,755 - $61,294	6,306 Added 19.17%	39,203 $160,000
Q3 2018 Nov 09, 2018	BUY	$10.0 - $19.02 $12,820 - $24,383	1,282 Added 4.06%	32,897 $0
Q2 2018 Aug 06, 2018	BUY	$14.2 - $22.68 $96,616 - $154,314	6,804 Added 27.42%	31,615 $564,000
Q1 2018 May 15, 2018	BUY	$13.56 - $18.48 $127,382 - $173,601	9,394 Added 60.93%	24,811 $392,000
Q4 2017 Feb 09, 2018	BUY	$14.95 - $19.9 $230,484 - $306,798	15,417	15,417 $254,000

Others Institutions Holding MRSN

# of Institutions

125

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

Eco R1 Capital, LLC San Francisco, CA

19.4M
Shares

$11.8 Million
1.59% of portfolio
Nextech Invest Ag

12.1M
Shares

$7.36 Million
3.72% of portfolio
Vr Adviser, LLC New York, NY

11.3M
Shares

$6.91 Million
2.22% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

8.66M
Shares

$5.28 Million
2.94% of portfolio
Black Rock Inc. New York, NY

8.38M
Shares

$5.11 Million
0.0% of portfolio

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $59.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account